PET measures of benzodiazepine receptors in progressive supranuclear palsy
Norman L. Foster(University of Utah), S. Gilman(Sahlgrenska University Hospital), Satoshi Minoshima(University of Utah), Roderick J. A. Little(University of Michigan), Jewel Johanns(Johnson & Johnson (United States)), Mary Heumann(University of Michigan), Dietmar Kuhl(Universität Hamburg)
Cited by 59
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2019|1.2k
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
|New England Journal of Medicine|2012|1.1k